Clinical Trials for CyanVac

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: CyanVac

Clinical Trials (3)

NCT06967181
A Phase 1 Trial of Intranasal Mumps Virus Vaccines in Healthy Adults
PHASE1Active, not recruiting
60 participants
Started: May 14, 2025 · Completed: Nov 30, 2026
1 condition1 sponsor3 locations
NCT06742281
A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults
PHASE2Recruiting
10,016 participants
Started: Dec 5, 2024 · Completed: Jun 30, 2027
1 condition2 sponsors55 locations
NCT05736835
A Phase 2 Trial of the Immunogenicity and Safety of CVXGA Intranasal COVID Vaccine in Healthy Adults
PHASE2Active, not recruiting
227 participants
Started: Jun 30, 2023 · Completed: Jun 30, 2028
1 condition1 sponsor10 locations